[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company's product candidates include Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, 3.6% for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms, as part of menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia, or pain during sexual intercourse; and DARE-CIN for cervical intraepithelial neoplasia and other human papillomavirus related pathologies treatment. It is also developing DARE-PDM1 to treat primary dysmenorrhea; DARE-204 and DARE-214 that provides contraception over 6-month and 12-month periods, respectively; DARE-FRT1 for luteal phase support as part of an in vitro fertilization treatment plan; DARE-PTB1 for the prevention of preterm birth; DARE-LARC1, a contraceptive implant; DARE-LBT for vaginal health support; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. The company also offers XACIATO, for the treatment of bacterial vaginosis in female patients 12 years of age and older. It has a license agreement with Organon & Co., Organon International GmbH, Bayer, Douglas Pharmaceuticals Limited, and Hennepin Life Sciences LLC. Dar\u00e9 Bioscience, Inc. is headquartered in San Diego, California.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 56, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 804068, "exercisedValue": 0, "unexercisedValue": 13557}, {"maxAge": 1, "name": "Ms. Lisa  Walters-Hoffert", "age": 64, "title": "Executive Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 523200, "exercisedValue": 0, "unexercisedValue": 5214}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 68, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend", "title": "Chief Scientific Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4849, "open": 0.46, "dayLow": 0.28, "dayHigh": 0.4801, "regularMarketPreviousClose": 0.4849, "regularMarketOpen": 0.46, "regularMarketDayLow": 0.28, "regularMarketDayHigh": 0.4801, "beta": 1.21, "forwardPE": -3.53375, "volume": 4217254, "regularMarketVolume": 4217254, "averageVolume": 424662, "averageVolume10days": 578530, "averageDailyVolume10Day": 578530, "ask": 0.281, "askSize": 100, "marketCap": 28434532, "fiftyTwoWeekLow": 0.27, "fiftyTwoWeekHigh": 1.1, "priceToSalesTrailing12Months": 10.126673, "fiftyDayAverage": 0.45942, "twoHundredDayAverage": 0.49105, "currency": "USD", "enterpriseValue": 19362916, "floatShares": 98894136, "sharesOutstanding": 100582000, "sharesShort": 235035, "sharesShortPriorMonth": 530539, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0023, "heldPercentInsiders": 0.01653, "heldPercentInstitutions": 0.0661, "shortRatio": 0.68, "shortPercentOfFloat": 0.0023999999, "impliedSharesOutstanding": 170855008, "bookValue": -0.05, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -30161392, "trailingEps": -0.35, "forwardEps": -0.08, "lastSplitFactor": "1:10", "lastSplitDate": 1500508800, "enterpriseToRevenue": 6.896, "enterpriseToEbitda": -0.631, "52WeekChange": -0.717, "SandP52WeekChange": 0.2160933, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "DARE", "underlyingSymbol": "DARE", "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "firstTradeDateEpochUtc": 1397136600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "79b82021-a19d-3c2b-be19-b7a9d44205d1", "messageBoardId": "finmb_423979060", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2827, "targetHighPrice": 6.0, "targetLowPrice": 2.0, "targetMeanPrice": 4.5, "targetMedianPrice": 5.0, "recommendationMean": 2.2, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 10476056, "totalCashPerShare": 0.104, "ebitda": -30701516, "totalDebt": 1404469, "quickRatio": 0.558, "currentRatio": 0.857, "totalRevenue": 2807885, "revenuePerShare": 0.032, "returnOnAssets": -0.59016997, "returnOnEquity": -9.94692, "freeCashflow": -27184968, "operatingCashflow": -38856656, "operatingMargins": -2.74988, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-18"}]